Key result
Integrating FoCUS-detected RWMA into the HEART score increases sensitivity for high-risk NSTE-ACS by ~54%.
Why the study?
This study evaluated whether adding Focused Cardiac Ultrasound (FoCUS) could enhance risk stratification in emergency department patients evaluated for acute coronary syndrome using HEAR and HEART scores.
Does integrating Focused Cardiac Ultrasound (FoCUS) for regional wall motion abnormalities into HEAR and HEART scores improve risk stratification for NSTE-ACS in emergency department patients with chest pain?
Cohort (n=684)
No
Does integrating Focused Cardiac Ultrasound (FoCUS) for regional wall motion abnormalities into HEAR and HEART scores improve risk stratification for NSTE-ACS in emergency department patients with chest pain?
Odds Ratio: 3.1 (95% CI 1.66–5.78)
p-value: p=<0.001
Integrating focused cardiac ultrasound to detect regional wall motion abnormalities into the HEART score improves sensitivity and risk stratification for NSTE-ACS in emergency department patients with chest pain.
May improve NSTE-ACS detection when added to HEART score; hypothesis-generating pending randomized outcome trials.
Chest pain (CP) is a common emergency department (ED) presenting symptom, requiring rapid assessment for acute coronary syndrome (ACS). The HEAR and HEART scores have been proposed to streamline patient evaluation. This study evaluated whether adding Focused Cardiac Ultrasound (FoCUS) could enhance risk stratification. Analysis of a prospective observational study involving adult patients at the ED of a University Hospital in Italy in 2022. Patients were stratified by the HEAR score into low (≤ 1) and mid-high risk (≥ 2) groups, and HEART score into low (≤ 3), mid (4–6), and high-risk (≥ 7) groups. All patients underwent FoCUS for regional wall motion abnormalities (RWMA). The primary outcome was non-ST-elevation (NSTE)-ACS within 30 days. We included 684 patients with median age of 58 years and 40% females. NSTE-ACS occurred in 106 (16%) patients, with 0/123 (0%) and 106/561 (19%) in low and mid-high-risk HEAR groups, respectively, and 6/337 (2%), 63/278 (23%) and 37/69 (54%) in low, mid and high-risk HEART groups, respectively. RWMA was found in 87 (13%) patients. In HEAR ≥ 2 (53% vs 13%, p < 0.001) and HEART 4–6 patients (50% vs 17%, p < 0.001), RWMA were associated with a higher frequency of NSTE-ACS. Multivariable analysis confirmed RWMA as an independent predictor of NSTE-ACS (OR 3.10, 95%CI 1.66–5.78). Including RWMA into the HEART score increased its sensitivity for high-risk patients (0.54 vs 0.35).Integrating RWMA identified by FoCUS into the HEAR and HEART scores might improve risk stratification for NSTE-ACS in patients presenting to the ED with chest pain.
No takes yet. Share an insight, caveat, or question.
Rossetto et al. (2026) conducted a cohort in Chest pain suspected of acute coronary syndrome (n=684). Regional wall motion abnormalities (RWMA) detected by Focused Cardiac Ultrasound (FoCUS) vs. Absence of RWMA was evaluated on Non-ST-elevation acute coronary syndrome (NSTE-ACS) within 30 days (OR 3.10, 95% CI 1.66-5.78, p=<0.001). The presence of regional wall motion abnormalities detected by focused cardiac ultrasound was an independent predictor of 30-day non-ST-elevation acute coronary syndrome (OR 3.10).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: